Last update 01 Nov 2024
Syngene International Ltd.
Last update 01 Nov 2024
Overview
Basic Info
Introduction Syngene International Ltd. is a worldwide discovery, development, and manufacturing organization that offers comprehensive scientific services to diverse industries. The company specializes in contract research and manufacturing services, offering a range of services including discovery chemistry and biology, safety assessment, large molecule and chemical development, formulation development, stability studies, and polymer research. It also focuses on integrated discovery and development along with clinical development. Founded on November 18, 1993, the company is based in Bangalore, India. |
Tags
Other Diseases
Nervous System Diseases
Immune System Diseases
Small molecule drug
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial toEvaluate the Efficacy and Safety of ME-015 (Suplatast Tosilate) in Cough Related to Idiopathic Pulmonary Fibrosis - COSMIC – IPF
A Phase II, Multi-center, Single-arm, Open-label Study to Assess the Efficacy and Safety of Tenalisib, a PI3K d/?, and SIK3 Inhibitor, in Patients with Metastatic Triple Negative Breast Cancer (TNBC) - NIL
A Multicenter, Open-label, Single-arm, Post Approval for Restricted use under Emergency Situation Study, to Evaluate the Safety and Efficacy of Injection Remdesivir 100mg (Lyophilized) Manufactured by Syngene International limited in Patients with Corona Virus Disease 2019.
100 Clinical Results associated with Syngene International Ltd.
Login to view more data
Login to view more data
19 Jul 2024Organic Process Research & Development
Analytical Strategy for Low-Level Estimation of Unstable Genotoxic Boronate Ester Impurities
Author: Mangalampalli, Venkata Phanikrishna Sharma ; Purandharan, Devikumar ; Gandhi, Santosh ; Jayaraman, Karthik ; Kushwah, Bhoopendra Singh ; Young, Joel ; Bajpai, Lakshmikant ; Rajendran, Ashok Kumar
28 Jun 2024Organic Letters
Organic Photoredox-Catalyzed S-Trifluoromethylation of Aromatic and Heteroaromatic Thiols
Article
Author: Tester, Richland ; Mathur, Arvind ; Sarmah, Manash Pratim ; Bhattacharyya, Aditya ; Muthukumar, M ; Vadde, Veeresh
18 Jun 2024ChemistrySelect
Tunable Synthesis of Pyrazolo Oxepines, Pyrazolo Thiophenes and 1H‐Indazoles Using Alkylation, Aldol Condensation and Thermal Rearrangement
Author: Gupta, Anuradha ; Akunuri, Arun ; Pavan, Mysore S. ; Byri, Vijay Kumar ; Ulaganathan, Sankar ; Pitchai, Manivel ; Chikkananjaiah, Nanjundaswamy Kanikahalli ; Vetrichelvan, Muthalagu ; Reddy, Thirupala ; Mathur, Arvind ; Venkateshappa, Suresh Shagathur
14 Oct 2024
Clinical ResultDrug ApprovalPhase 2ADC
100 Deals associated with Syngene International Ltd.
Login to view more data
100 Translational Medicine associated with Syngene International Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 24 Dec 2024
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
3
1
NDA/BLA
Other
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free